Cargando…

Update on Sjögren’s Syndrome 2018

Primary Sjögren’s syndrome (pSS) is a chronic systemic autoimmune disease with a diverse clinical picture, extending from exocrine involvement to extraglandular manifestations. Although pSS remains a disease of unknown etiology, an interaction between genetic susceptibility and environmental trigger...

Descripción completa

Detalles Bibliográficos
Autores principales: Argyropoulou, Ourania D., Tzioufas, Athanasios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045943/
https://www.ncbi.nlm.nih.gov/pubmed/32185326
http://dx.doi.org/10.31138/mjr.29.4.193
_version_ 1783501875665960960
author Argyropoulou, Ourania D.
Tzioufas, Athanasios G.
author_facet Argyropoulou, Ourania D.
Tzioufas, Athanasios G.
author_sort Argyropoulou, Ourania D.
collection PubMed
description Primary Sjögren’s syndrome (pSS) is a chronic systemic autoimmune disease with a diverse clinical picture, extending from exocrine involvement to extraglandular manifestations. Although pSS remains a disease of unknown etiology, an interaction between genetic susceptibility and environmental triggers is thought to play a key role in disease initiation and progress. Despite the extensive research during the past years, the pathogenetic mechanisms are still elusive and effective therapeutic intervention is still missing. This review aims to provide an overview of the recent literature on the pathogenesis, clinical features and new therapeutic aspects of pSS.
format Online
Article
Text
id pubmed-7045943
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Mediterranean Journal of Rheumatology (MJR)
record_format MEDLINE/PubMed
spelling pubmed-70459432020-03-17 Update on Sjögren’s Syndrome 2018 Argyropoulou, Ourania D. Tzioufas, Athanasios G. Mediterr J Rheumatol Review Primary Sjögren’s syndrome (pSS) is a chronic systemic autoimmune disease with a diverse clinical picture, extending from exocrine involvement to extraglandular manifestations. Although pSS remains a disease of unknown etiology, an interaction between genetic susceptibility and environmental triggers is thought to play a key role in disease initiation and progress. Despite the extensive research during the past years, the pathogenetic mechanisms are still elusive and effective therapeutic intervention is still missing. This review aims to provide an overview of the recent literature on the pathogenesis, clinical features and new therapeutic aspects of pSS. The Mediterranean Journal of Rheumatology (MJR) 2018-12-18 /pmc/articles/PMC7045943/ /pubmed/32185326 http://dx.doi.org/10.31138/mjr.29.4.193 Text en © 2018 The Mediterranean Journal of Rheumatology (MJR) http://creativecommons.org/licenses/by/4.0/ This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Review
Argyropoulou, Ourania D.
Tzioufas, Athanasios G.
Update on Sjögren’s Syndrome 2018
title Update on Sjögren’s Syndrome 2018
title_full Update on Sjögren’s Syndrome 2018
title_fullStr Update on Sjögren’s Syndrome 2018
title_full_unstemmed Update on Sjögren’s Syndrome 2018
title_short Update on Sjögren’s Syndrome 2018
title_sort update on sjögren’s syndrome 2018
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045943/
https://www.ncbi.nlm.nih.gov/pubmed/32185326
http://dx.doi.org/10.31138/mjr.29.4.193
work_keys_str_mv AT argyropoulououraniad updateonsjogrenssyndrome2018
AT tzioufasathanasiosg updateonsjogrenssyndrome2018